March 20, 2025
MuCopilot: digital biomarkers in cystic fibrosis
Development of new digital biomarkers on smartphones to support recent advances in the management of cystic fibrosis
In March 2025, in Paris, France, during the Scientific Days on Cystic Fibrosis, we presented the development of our mobile application, MuCopilot, dedicated to the collection of digital biomarkers in patients with cystic fibrosis.
It enables reliable and continuous home-based assessment of respiratory and physical capacities, aiming to reduce the burden of care and to complement traditional clinical assessments.